Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Inventory Average (2016 - 2025)

Historic Inventory Average for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $19.8 million.

  • Trinity Biotech's Inventory Average fell 1337.25% to $19.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $19.8 million, marking a year-over-year decrease of 1337.25%. This contributed to the annual value of $19.7 million for FY2024, which is 737.35% down from last year.
  • Trinity Biotech's Inventory Average amounted to $19.8 million in Q2 2025, which was down 1337.25% from $20.6 million recorded in Q4 2024.
  • Trinity Biotech's Inventory Average's 5-year high stood at $36.1 million during Q2 2021, with a 5-year trough of $19.8 million in Q2 2025.
  • Moreover, its 5-year median value for Inventory Average was $22.8 million (2024), whereas its average is $25.6 million.
  • In the last 5 years, Trinity Biotech's Inventory Average surged by 1269.49% in 2021 and then tumbled by 2504.68% in 2023.
  • Over the past 5 years, Trinity Biotech's Inventory Average (Quarter) stood at $30.6 million in 2021, then decreased by 24.79% to $23.0 million in 2022, then fell by 11.38% to $20.4 million in 2023, then grew by 0.89% to $20.6 million in 2024, then fell by 4.07% to $19.8 million in 2025.
  • Its Inventory Average was $19.8 million in Q2 2025, compared to $20.6 million in Q4 2024 and $22.4 million in Q3 2024.